About DAB
DAB is a Healthcare company based in Delft (Netherlands) founded in 2012 by Sef Heijnen. It operates as a technology solutions for accelerated fermentation of renewable feedstocks are provided. DAB has raised $2.23 million across 2 funding rounds from investors including InnovationQuarter, FORWARD.one and Navus Ventures. Its chief executive is Kirsten Herben Steinbusch. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Bioreactors. Its competitors include Unibio, Univercells Tech, Nirrin Technologies, Pow.Bio and Caladan Bio and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
DAB was founded in 2012 in Delft, Netherlands, as a provider of technology solutions in the biotechnology sector. Accelerated fermentation processes are enabled to produce chemicals, materials, and fuels from renewable feedstocks. Solutions are also offered for fermentations involving water-insoluble products. Operations focus on industrial applications within sustainable manufacturing.
- Total Equity Funding$2.23M (USD)
in 2 rounds
- InvestorsInnovationQuarter
& 3 more
Funding Insights of DAB
DAB has successfully raised a total of $2.23M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.23M
- Total Rounds 2
- First Round $2.23M
(May 2019)
- Investors Count 4
All 2 funding rounds of DAB with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | – | Series A | – | – | |
| May 2019 | $2.23M | Series A | – | InnovationQuarter |
4 investors in total: 4 institutional.
Investors in DAB
DAB has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include InnovationQuarter, FORWARD.one and Navus Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sector-agnostic VC firm investing primarily in the Netherlands | 2013 | innovationquarter.nl | The Hague, Netherlands | |
Venture capital investments are made in early-stage European tech startups. | – | forward.one | Amstelveen, Netherlands | |
High-tech startups are funded across early and growth stages. | – | navusventures.com | - | |
Investments are directed by Capricorn Partners into European tech ventures. | – | capricorn.be | - |
Investor details for DAB
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DAB
13 people are tracked at DAB (5 in leadership, 4 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Sef Heijnen | Co-Founder | Leadership |
Kirsten Herben Steinbusch | CEO | Leadership |
Willem-Jan Meijer | Chief Commercial Officer (cco) | Leadership |
Eric Van Der Meer | Chief Executive Officer | Leadership |
Kirsten Steinbusch | CTO | Leadership |
Andreas Worberg | Advisor | Board & advisors |
Rainer Figge | Advisor | Board & advisors |
Luuk Van Der Wielen | Co-Founder & Scientific Advisor | Board & advisors |
Joep Hofmeester | Advisor | Board & advisors |
Marion van Lotringen | Senior Process Engineer | Team |
Anouk Mulder | Office Manager | Team |
Pieter Nelisse | Principal Scientist | Team |
Arjan Oudshoorn | Principal Engineer | Team |
Complete people profiles for DAB
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of DAB
3 dated milestones of DAB across 13 years, from founding to its latest funding, stage changes and deals.
- Founded DAB is founded.
- Funding First funding round of $2.2M.
- Funding Latest funding round, Series A,.
Competitors of DAB
DAB has 8 listed competitors in our database, 4 of them funded. They include Unibio, Univercells Tech, Nirrin Technologies, Pow.Bio and Caladan Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unibio.dk | 2001 | Odense, Denmark | $30M | 59 | Animal feed supplements are produced using proprietary fermentation technology. | |
| univercellstech.com | 2020 | Nivelles, Belgium | – | 74 | Intensified biomanufacturing technologies for viral production are developed and manufactured. | |
| nirrin.tech | 2018 | Billerica, United States | $4.82M | 17 | Developer of sensor and integration technologies for continuous control and bioprocess automation | |
| pow.bio | 2019 | Berkeley, United States | $9.5M | – | Intelligent fermentation services for industrial and synthetic biology are provided. | |
| caladan.bio | 2023 | Brooklyn, United States | $5.11M | – | Modular bioreactors are developed for biotechnology research applications. | |
| biozeen.com | 2005 | Bengaluru, India | – | 194 | Customized bioprocess equipment and automation solutions are provided for biopharmaceuticals. | |
| brightpathlabs.com | 2019 | Santa Fe, United States | – | – | Spinning tube-in-tube continuous-flow reactors are developed for drug manufacturing. | |
| tecnic.eu | 2011 | Girona, Spain | – | – | Bioprocess equipment is developed for cell culture and microbial applications. |
Detailed competitors of DAB
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of DAB
The website of DAB (dab.bio) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 143.8% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as DAB (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DAB
DAB was founded in 2012 and raised its 1st funding round 7 years after it was founded.
DAB is headquartered in Delft, Netherlands. It is registered at Delft, South Holland, Netherlands.
Kirsten Herben Steinbusch is the current CEO of DAB.
DAB is a funded company, having raised a total of $2.23M across 2 funding rounds to date. The company's 1st funding round was a Series A of $2.23M, raised on May 2019.
DAB was founded in 2012 in Delft, Netherlands, as a provider of technology solutions in the biotechnology sector. Accelerated fermentation processes are enabled to produce chemicals, materials, and fuels from renewable feedstocks. Solutions are also offered for fermentations involving water-insoluble products. Operations focus on industrial applications within sustainable manufacturing.
DAB's top competitors include Unibio, Univercells Tech and Nirrin Technologies.
DAB has 4 investors. Key investors include InnovationQuarter, FORWARD.one, Navus Ventures, and Capricorn Partners.